跳至主要内容
临床试验/NCT03759743
NCT03759743已完成不适用

a Randomised, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject

Medy-Tox1 个研究点 分布在 1 个国家目标入组 97 人开始时间: 2018年9月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
97
试验地点
1
主要终点
change from baseline fat percentage at 12 week

研究概览

简要总结

The purpose of this study is to evaluate the safety and efficacy of LMT1-48(Probiotics) compared to a placebo in reducing the body fat in overweight subjects

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age between 19 and 70 years
  • Overweight (25 kg/m2 ≤ body mass index (BMI) < 30 kg/m2)

排除标准

  • Pregnancy or breast-feeding
  • Unstable body weight (body weight change > 10% within 3 months before screening)

结局指标

主要结局

change from baseline fat percentage at 12 week

时间窗: at baseline and 12-week follow-up

the body composition of the subjects was measured via dual-energy X-ray absorptiometry (DEXA) to determine

次要结局

未报告次要终点

研究者

发起方
Medy-Tox
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验